| Christopher Rowlett, DPM | |
|
4802 E Johnson Ave, Jonesboro, AR 72401 | |
| (870) 936-8000 | |
| (870) 934-3633 |
| Full Name | Christopher Rowlett |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 20 Years |
| Location | 4802 E Johnson Ave, Jonesboro, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184756280 | NPI | - | NPPES |
| 164659717 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 238 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Memorial Hospital Jonesboro, Inc. | Jonesboro, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northeast Arkansas Clinic Charitable Foundation, Inc. | 2961547526 | 228 |
News Archive
Neogenix Oncology, Inc. announced today that it will present data from its new serum biomarker ELISA utilizing its NPC-1C antibody for patients with colorectal and pancreatic cancers. Results from the study will be presented at the American Society of Clinical Oncology (ASCO)-NCI-EORTC Annual Meeting on Molecular Makers in Cancer, to be held in Hollywood, Florida from October 18-20, 2010.
The Wall Street Journal on Wednesday examined how the "ailing economy" has prompted many nurses to work additional shifts, delay retirement or return to the work force from retirement - all of which have helped "ease the nursing shortage."
A team of engineers and biotechnologists at the University of Freiburg has for the first time shown in mammals that the concentration of antibiotics in the body can be determined using breath samples. The breath measurements also corresponded to the antibiotic concentrations in the blood.
Johnson & Johnson has announced it has extended its previously announced cash tender offer, through its wholly-owned subsidiary, Binder Merger Sub, Inc., for all outstanding shares of common stock of Omrix Biopharmaceuticals, Inc. until 12:00 midnight (Eastern time), on Dec. 26, 2008, unless further extended.
Allos Therapeutics, Inc. today reported new analyses of data from the Company's pivotal PROPEL trial of FOLOTYN (pralatrexate injection) in patients with relapsed or refractory peripheral T-cell lymphoma at the 52nd American Society of Hematology Annual Meeting held in Orlando, Florida.
› Verified 8 days ago
| Provider Name | Northeast Arkansas Clinic Charitable Foundation, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1861721839 PECOS PAC ID: 2961547526 Enrollment ID: O20100315000190 |
News Archive
Neogenix Oncology, Inc. announced today that it will present data from its new serum biomarker ELISA utilizing its NPC-1C antibody for patients with colorectal and pancreatic cancers. Results from the study will be presented at the American Society of Clinical Oncology (ASCO)-NCI-EORTC Annual Meeting on Molecular Makers in Cancer, to be held in Hollywood, Florida from October 18-20, 2010.
The Wall Street Journal on Wednesday examined how the "ailing economy" has prompted many nurses to work additional shifts, delay retirement or return to the work force from retirement - all of which have helped "ease the nursing shortage."
A team of engineers and biotechnologists at the University of Freiburg has for the first time shown in mammals that the concentration of antibiotics in the body can be determined using breath samples. The breath measurements also corresponded to the antibiotic concentrations in the blood.
Johnson & Johnson has announced it has extended its previously announced cash tender offer, through its wholly-owned subsidiary, Binder Merger Sub, Inc., for all outstanding shares of common stock of Omrix Biopharmaceuticals, Inc. until 12:00 midnight (Eastern time), on Dec. 26, 2008, unless further extended.
Allos Therapeutics, Inc. today reported new analyses of data from the Company's pivotal PROPEL trial of FOLOTYN (pralatrexate injection) in patients with relapsed or refractory peripheral T-cell lymphoma at the 52nd American Society of Hematology Annual Meeting held in Orlando, Florida.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Rowlett, DPM Po Box 1960, Jonesboro, AR 72403-1960 Ph: (870) 936-8000 | Christopher Rowlett, DPM 4802 E Johnson Ave, Jonesboro, AR 72401 Ph: (870) 936-8000 |
News Archive
Neogenix Oncology, Inc. announced today that it will present data from its new serum biomarker ELISA utilizing its NPC-1C antibody for patients with colorectal and pancreatic cancers. Results from the study will be presented at the American Society of Clinical Oncology (ASCO)-NCI-EORTC Annual Meeting on Molecular Makers in Cancer, to be held in Hollywood, Florida from October 18-20, 2010.
The Wall Street Journal on Wednesday examined how the "ailing economy" has prompted many nurses to work additional shifts, delay retirement or return to the work force from retirement - all of which have helped "ease the nursing shortage."
A team of engineers and biotechnologists at the University of Freiburg has for the first time shown in mammals that the concentration of antibiotics in the body can be determined using breath samples. The breath measurements also corresponded to the antibiotic concentrations in the blood.
Johnson & Johnson has announced it has extended its previously announced cash tender offer, through its wholly-owned subsidiary, Binder Merger Sub, Inc., for all outstanding shares of common stock of Omrix Biopharmaceuticals, Inc. until 12:00 midnight (Eastern time), on Dec. 26, 2008, unless further extended.
Allos Therapeutics, Inc. today reported new analyses of data from the Company's pivotal PROPEL trial of FOLOTYN (pralatrexate injection) in patients with relapsed or refractory peripheral T-cell lymphoma at the 52nd American Society of Hematology Annual Meeting held in Orlando, Florida.
› Verified 8 days ago
Family Foot & Ankle Center Podiatrist Medicare: Medicare Enrolled Practice Location: 1000 Windover, Suite A, Jonesboro, AR 72401 Phone: 870-934-8200 Fax: 870-934-8219 | |
Podiatry Group The Foot Doctors Ltd Podiatrist Medicare: Medicare Enrolled Practice Location: 637 E Matthews Ave, Jonesboro, AR 72401 Phone: 870-931-3338 Fax: 870-935-9084 | |
Dr. Lee Paul Woodruff, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1815 Executive Sq, Jonesboro, AR 72401 Phone: 870-933-0041 Fax: 870-933-0531 | |
Dr. Eddy Lloyd Caldwell, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 406 E Washington Ave, Jonesboro, AR 72401 Phone: 870-933-8900 Fax: 870-933-2611 | |
Dr. Walter Wadsworth Hayes, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1000 Windover, Suite A, Jonesboro, AR 72401 Phone: 870-934-8200 Fax: 870-934-8219 | |
Dr. William George Coates Jr., D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 637 E Matthews Ave, Jonesboro, AR 72401 Phone: 870-931-3338 Fax: 870-935-9084 |